Sarepta Therapeutics Inc.

In News

SRPT Looks 81.5% Undervalued on GF Value™ Amid Rare Disease Tria - GuruFocus

GuruFocus - Sep 20, 2026

SRPT Stock Drops 4% As Citi Flags Potentially Stronger Rival In Duchenne Space - Stocktwits

Stocktwits - Sep 20, 2026

Sarepta Therapeutics Announces Second Quarter 2026 Financial Results and Recent Corporate Developments - Sarepta Therapeutics

Sarepta Therapeutics - Aug 05, 2026

Sarepta Therapeutics stock gains analyst support after mixed rating signals - AD HOC NEWS

AD HOC NEWS - Sep 20, 2026

Sarepta Therapeutics Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Sarepta Therapeutics, Inc. - SRPT - Business Wire

Business Wire - Aug 24, 2026

Sarepta Sees ELEVIDYS Demand Stabilizing as FSHD, DM1 Readouts Near - Yahoo Finance

Yahoo Finance - Sep 15, 2026

Dyne, Sarepta shares tumble as Novartis setback weighs on muscle disease drug developers - Reuters

Reuters - Sep 08, 2026

Sarepta Bats Away Investors’ Duchenne Therapy Safety Lawsuit - Bloomberg Law News

Bloomberg Law News - Sep 16, 2026

Massachusetts Judge Bars Sarepta Therapeutics Investor Suit Over Alleged Risk Misstatements - Lawxy AI

Lawxy AI - Sep 17, 2026

This Analyst Sees 34% Upside For SRPT Stock — Here's Why They Expect A Sustained Rally Next - Stocktwits

Stocktwits - Sep 19, 2026

Sarepta Therapeutics Announces Fourth Quarter and Full-Year 2025 Financial Results and Recent Corporate Developments - Sarepta Therapeutics

Sarepta Therapeutics - Feb 25, 2026

Sarepta Therapeutics to Present at the Morgan Stanley 24th Annual Global Healthcare Conference - Yahoo Finance

Yahoo Finance - Aug 31, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment